Morpholinyl anthracyclines: Option for reversal of anthracycline resistance
- 31 December 1990
- journal article
- editorial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (6) , 659-660
- https://doi.org/10.1016/0277-5379(90)90110-f
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Multidrug resistance and its circumventionEuropean Journal of Cancer and Clinical Oncology, 1990
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- DNA Cross-linking and Cytotoxicity of the Alkylating Cyanomorpholino Derivative of Doxorubicin in Multidrug-Resistant Cells2JNCI Journal of the National Cancer Institute, 1988
- Multidrug Resistance1JNCI Journal of the National Cancer Institute, 1988
- Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and-resistant P388 cellsCancer Chemotherapy and Pharmacology, 1986
- The Anticancer Agent Adriamycin Can Be Actively Cytotoxic Without Entering CellsScience, 1982